MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients

Circulating tumor cells (CTCs) in blood are accepted as a prognostic marker for patients with metastatic colorectal cancer (CRC). However, there is limited data on the use of CTCs as a prognostic marker for non-metastatic patients. In the current study, we used a rare cell automated analysis platfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chun-Chi, Yang, Chih-Yung, Hung, Tzu-Chao, Wang, Chun-Hung, Wei, Sheng-Wen, Schiro, Perry, Tseng, Ju-Yu, Lin, Chi-Hung, Jiang, Jeng-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036555/
https://www.ncbi.nlm.nih.gov/pubmed/36959311
http://dx.doi.org/10.1038/s41598-023-31346-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036555/
https://www.ncbi.nlm.nih.gov/pubmed/36959311
http://dx.doi.org/10.1038/s41598-023-31346-9

Ejemplares similares